Gary. I actually used to work in the kidney industry for
Gary. I actually used to work in the kidney industry for the largest dialysis company in the world and I can say that they are aware of this product but at least at my level nothing in how to address it as competition. The clinics will never go away but this will be a huge change for many. (Trust me I would love to see the clinic disappear but ESRD is typically a result of none compliance with high blood pressure, diabetes, or hypertension. The none compliance part is why the clinics will never all go away but this device will cause a major shift in the way dialysis is performed)
Regarding the FDA even earlier in my career I was a Chemist for an injection contract manufacturing site. I can't say I agree with all regulations but I will say this. Some of the products that are given out in the millions every year have risks of mercury, cyanide, even LSD. These are just a few products used to formulate or by products from the formulation that has to be removed from the finished produce. Even how things are stored once packaged is such a huge part of the quality of the product. The chemicals degrade at different tempuratures or like Johnson and Johnson found out with their Tylenol plant years ago... the new pallets treated with pesticides when stored in their warehouse was leaching the pesticide into tylenol. It took the FDA showing up twice to get them to fix it. The second time they showed up with 30 some inspectors and locked the plant down for a month... then they ultimately shut the plant down. I had moved from a Chemist to an auditor by this point which is the only reason I really remember it but if you look about about tylenol recalls in the last 10 years or so you will find it.
So long story short. I rather see the FDA get more staff and develop ways to be efficient in their oversight than to limit the oversight. The US public is a fix me now society which is part of the reason we have the opioid epidemic. We will pretty much take any pill or any shot as long as someone tells us it will help whatever we feel is currently wrong.
Really do love the portable Dialysis Machine it's going to be a game changer. Is his company public or taking private funding?
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...
Continue Reading
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...
Continue Reading
Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...
Continue Reading
Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...
Continue Reading
Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...
Continue Reading
A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...
Continue Reading
A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...
Continue Reading
High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...
Continue Reading
The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...
Continue Reading
Top 5 Most Recently Viewed Articles
FDB Recognized for Excellence in Workplace Culture Employee satisfaction awards from two significant metropolitan regions showcase FDB's commitment to its dedicated team, which continuously strives to enhance medication decisions. Top Workplace Recognition FDB (First Databank, Inc.), known for its trusted drug knowledge, has been recognized as a Top Workplace for 2025 in...
Continue Reading
Northampton Capital Partners Collaborates with Altius Renewable Royalties Northampton Capital Partners LLC, recognized for its strategic investment approach, has announced that an affiliated entity has entered into a definitive agreement with Altius Renewable Royalties Corp. This partnership is set to bolster the operational capabilities of Altius Renewable Royalties...
Continue Reading
FMC Corporation Set to Announce Second Quarter Earnings FMC Corporation (NYSE: FMC) has announced its upcoming schedule to release second quarter earnings information. This event is important for investors, partners, and stakeholders who are monitoring the company’s performance in the agricultural sector. The earnings release is slated for a Wednesday after market...
Continue Reading
Introduction to AC03-CS Series Resistors Vishay Intertechnology, Inc. has introduced an exciting innovation in its AC03-CS series of axial cemented, leaded wirewound safety resistors. These robust devices now feature the WSZ lead form, which enhances their usability by allowing for efficient assembly practices. Designed for optimal performance, this addition signifies a...
Continue Reading
Important Updates for Hims & Hers Investors NEW YORK and NEW ORLEANS — In a significant development concerning Hims & Hers Health, Inc. (NASDAQ: HIMS), former Attorney General of Louisiana, Charles C. Foti, Jr., partnered with Kahn Swick & Foti, LLC, emphasizes the urgency for investors who have suffered losses exceeding $100,000 to take action. Investors are reminded...
Continue Reading
